Dr. Bryan Hansen is a systems neuroscientist and data scientist with more than 10 years of experience developing novel electrophysiological and behavioral paradigms. His studies began in non-human primates, and mouse animal models, then extended findings to patients with epilepsy, and finally to digitally enabled clinical trials. Relying on his training as a neuroscientist and utilizing his data science skillset, Bryan constantly seeks to bridge the gap between biology and computation using innovative methods in signal processing, statistics, and predictive analytics. This work has been published and cited in many high-profile journals and presented internationally.
Currently, Bryan is the Director of Data Science and Digital Health in Janssen Research & Development (JRD), leading the digital health strategy for Neurodegeneration. In this role, he represents JRD Data Science across several clinical trials focused on driving impact for Janssen’s neurodegeneration programs. Externally, he represents Janssen within various consortia and partners closely with external innovation teams to identify novel datasets and solutions.
Before joining Janssen, Bryan was an associate principal scientist in the Global Digital Analytics and Technologies team at Merck Research Laboratories. Before joining Merck in 2015, Bryan was a post-doctoral fellow at the Salk Institute in the Systems Neurobiology Laboratories, where his work focused on neural mechanisms underlying attention-related changes in brain state. Bryan received his doctorate in Biomedical Sciences from the University of Texas Health Science Center, focusing on systems and computational neuroscience, and a Bachelor's in Neuroscience from Baylor University.